213 related articles for article (PubMed ID: 12845811)
1. Economic evaluation approaches for new technology.
Papatheofanis FJ
IEEE Eng Med Biol Mag; 2003; 22(3):16-7. PubMed ID: 12845811
[No Abstract] [Full Text] [Related]
2. Health technology assessment in the United Kingdom.
Akehurst R
Value Health; 2010 Jun; 13 Suppl 1():S4-5. PubMed ID: 20618794
[No Abstract] [Full Text] [Related]
3. New decision-making processes for the pricing of health technologies in Japan: The FY 2016/2017 pilot phase for the introduction of economic evaluations.
Shiroiwa T; Fukuda T; Ikeda S; Takura T
Health Policy; 2017 Aug; 121(8):836-841. PubMed ID: 28687183
[TBL] [Abstract][Full Text] [Related]
4. Could or Should We Use MCDA in the French HTA Process?
Ghabri S; Josselin JM; Le Maux B
Pharmacoeconomics; 2019 Dec; 37(12):1417-1419. PubMed ID: 31565761
[No Abstract] [Full Text] [Related]
5. Allocating resources.
Drummond MF
Int J Technol Assess Health Care; 1990; 6(1):77-92. PubMed ID: 2113892
[TBL] [Abstract][Full Text] [Related]
6. Medical technology assessment: economic evaluation of new technologies.
Adang EM; Dirksen CD; Engel GL; Baeten CG
Br J Hosp Med; 1995 Jun 7-20; 53(11):563-6. PubMed ID: 7655753
[TBL] [Abstract][Full Text] [Related]
7. Addressing the need for economic evaluation of cardiovascular medical devices in India.
Masurkar PP
Curr Probl Cardiol; 2024 Aug; 49(8):102677. PubMed ID: 38795804
[TBL] [Abstract][Full Text] [Related]
8. Estimating costs in the economic evaluation of medical technologies.
Luce BR; Elixhauser A
Int J Technol Assess Health Care; 1990; 6(1):57-75. PubMed ID: 2113891
[TBL] [Abstract][Full Text] [Related]
9. Technology assessment taking center stage in capital equipment acquisition process.
Werner C
Hosp Mater Manage; 1993 Mar; 18(3):8-9. PubMed ID: 10124669
[No Abstract] [Full Text] [Related]
10. Life-cycle management: a long-term challenge.
Newman C
Med Device Technol; 2003 Apr; 14(3):32-3. PubMed ID: 12789698
[TBL] [Abstract][Full Text] [Related]
11. Medical electronics: buy now.
European Coordination Committee of Radiological and Electromedical Manufacturers
Med Device Technol; 2003 Jun; 14(5):37. PubMed ID: 12852124
[No Abstract] [Full Text] [Related]
12. Intrinsic properties of medical devices: considerations for economic evaluation.
Basu R; Eggington S
Expert Rev Pharmacoecon Outcomes Res; 2019 Dec; 19(6):619-626. PubMed ID: 31721598
[No Abstract] [Full Text] [Related]
13. Can technology assessment control health spending?
Garber AM
Health Aff (Millwood); 1994; 13(3):115-26. PubMed ID: 7927142
[TBL] [Abstract][Full Text] [Related]
14. Does MCDA Trump CEA?
Campillo-Artero C; Puig-Junoy J; Culyer AJ
Appl Health Econ Health Policy; 2018 Apr; 16(2):147-151. PubMed ID: 29468578
[No Abstract] [Full Text] [Related]
15. Role of clinical pathways in health care provision: Focus on cancer treatment.
Kreys ED; Koeller JM
Am J Health Syst Pharm; 2013 Jun; 70(12):1081-5. PubMed ID: 23719888
[No Abstract] [Full Text] [Related]
16. Health technology assessment and economic evaluation across jurisdictions.
Simoens S
Value Health; 2010; 13(6):857-9. PubMed ID: 20701730
[No Abstract] [Full Text] [Related]
17. Improving the Methods for the Economic Evaluation of Medical Devices.
Tarricone R; Callea G; Ogorevc M; Prevolnik Rupel V
Health Econ; 2017 Feb; 26 Suppl 1():70-92. PubMed ID: 28139085
[TBL] [Abstract][Full Text] [Related]
18. Assessing new health technologies: lessons to be learned from drugs.
Henry DA; Hill SR
Med J Aust; 1999 Nov; 171(10):554-6. PubMed ID: 10816710
[TBL] [Abstract][Full Text] [Related]
19. Problems of using modelling in the economic evaluation of health care.
Sheldon TA
Health Econ; 1996; 5(1):1-11. PubMed ID: 8653188
[No Abstract] [Full Text] [Related]
20. Cost-effectiveness analysis in the assessment of diagnostic imaging technologies.
Gazelle GS; McMahon PM; Siebert U; Beinfeld MT
Radiology; 2005 May; 235(2):361-70. PubMed ID: 15858079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
